Company · CIK 0001664710 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Keros Therapeutics, Inc. · KROS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 SForm 4 → | Aug 20, 4:10 pm EDT | Annita TaniniCorp. Controller & VP, Finance | 1,224 | $10.29 | $12,595 | 45,144 | −2.64% | |
| Aug 18, 2026 SForm 4 → | Aug 20, 4:10 pm EDT | Lorena Raquel LernerChief Scientific Officer | 3,568 | $10.29 | $36,715 | 27,559 | −11.5% | |
| Aug 18, 2026 SForm 4 → | Aug 20, 4:10 pm EDT | Esther ChoChief Legal Officer | 4,485 | $10.29 | $46,151 | 35,770 | −11.1% | |
| Aug 18, 2026 SForm 4 → | Aug 20, 4:10 pm EDT | Charles W. NewtonDirector | 551 | $10.30 | $5,675 | 12,114 | −4.35% | 10b5-1 |
| Aug 17, 2026 PForm 4 → | Aug 19, 4:10 pm EDT | Jean Jacques BienaimeDirector | 1,000 | $10.27 | $10,270 | 19,592 | +5.38% | 10b5-1 |
| Jul 15, 2026 PForm 4 → | Jul 17, 4:10 pm EDT | Jean Jacques BienaimeDirector | 1,000 | $10.61 | $10,610 | 18,592 | +5.68% | 10b5-1 |
| Jul 1, 2026 AForm 4 → | Jul 6, 4:31 pm EDT | Anne PrenerDirector | 13,786 | — | — | 13,786 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 AForm 4 → | Jul 6, 4:31 pm EDT | Anne PrenerDirector | 14,870 | — | — | 14,870 | — |